| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |